FLGT FY 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$323M+13.8% YoY

Gross Profit

$131M40.6% margin

Operating Income

-$91M-28.2% margin

Net Income

-$61M-18.8% margin

EPS (Diluted)

$-1.97

Cash Flow

Operating Cash Flow

-$102M

Free Cash Flow

-$124M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$107M

Stockholders' Equity

$1.1B

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$323M	$283M	+13.8%
Gross Profit	$131M	$107M	+22.1%
Operating Income	-$91M	-$74M	-23.2%
Net Income	-$61M	-$43M	-41.7%